Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUCCINYLCHOLINE vs SULBACTAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUCCINYLCHOLINE vs SULBACTAM: Safety Overview

Metric SUCCINYLCHOLINE SULBACTAM
Total FAERS Reports 2,347 130
Deaths Reported 216 35
Death Rate 9.2% 26.9%
Hospitalizations 714 44
Average Patient Age 45.0 yrs 55.5 yrs
% Female Patients 59.8% 37.4%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Somerset Therapeutics, LLC N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A